MARKET

CDNA

CDNA

Caredx
NASDAQ
28.76
+0.25
+0.88%
Closed 19:25 07/13 EDT
OPEN
27.95
PREV CLOSE
28.51
HIGH
28.80
LOW
27.68
VOLUME
561.26K
TURNOVER
0
52 WEEK HIGH
30.00
52 WEEK LOW
10.96
MARKET CAP
1.49B
P/E (TTM)
-186.6321
1D
5D
1M
3M
1Y
5Y
1D
Cathie Wood reshuffles portfolio ahead of Q2, buys SpaceX, Eli Lilly, Meta; pares AMD, Roku
Seeking Alpha · 22h ago
Weekly Report: what happened at CDNA last week (0706-0710)?
Weekly Report · 1d ago
CareDx Refocuses Portfolio With Naveris Oncology Acquisition
TipRanks · 6d ago
CareDx completes sale of Lab Products unit to Eurobio Scientific for $171.2 million cash
PUBT · 6d ago
CareDx: The Transplant Platform Is Becoming A Specialty Diagnostics Compounder
Seeking Alpha · 6d ago
Weekly Report: what happened at CDNA last week (0629-0703)?
Weekly Report · 07/06 09:18
CareDx Closes Acquisition Of Naveris For Approx $260 Mln; Gains NavDx MRD Test For Cancer
NASDAQ · 07/02 07:07
CareDx completes acquisition of Naveris
PUBT · 07/01 20:05
More
About CDNA
CareDx, Inc. is a precision medicine diagnostics company advancing care in transplant, specialty oncology, and cell therapy. Through non-invasive longitudinal molecular biomarker testing, digital health, and patient support solutions, the Company is focused on improving patient outcomes. The Company's integrated solutions include non-invasive molecular testing for heart, kidney, and lung transplants; digital health technologies; and patient solutions that support care before and after transplant. The Company also provides genomic-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients.

Webull offers CareDx Inc stock information, including NASDAQ: CDNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDNA stock methods without spending real money on the virtual paper trading platform.